Syndrome des anticorps antiphospholipides : Questions médicales fréquentes
Nom anglais: Antiphospholipid Syndrome
Descriptor UI:D016736
Tree Number:C20.111.197
Termes MeSH sélectionnés :
Enterococcus
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome des anticorps antiphospholipides : Questions médicales les plus fréquentes",
"headline": "Syndrome des anticorps antiphospholipides : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome des anticorps antiphospholipides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-12",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome des anticorps antiphospholipides"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies auto-immunes",
"url": "https://questionsmedicales.fr/mesh/D001327",
"about": {
"@type": "MedicalCondition",
"name": "Maladies auto-immunes",
"code": {
"@type": "MedicalCode",
"code": "D001327",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.111"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome des anticorps antiphospholipides",
"alternateName": "Antiphospholipid Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D016736",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Doruk Erkan",
"url": "https://questionsmedicales.fr/author/Doruk%20Erkan",
"affiliation": {
"@type": "Organization",
"name": "Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, and Weill Cornell Medicine, New York, NY, USA."
}
},
{
"@type": "Person",
"name": "Hannah Cohen",
"url": "https://questionsmedicales.fr/author/Hannah%20Cohen",
"affiliation": {
"@type": "Organization",
"name": "Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK."
}
},
{
"@type": "Person",
"name": "Imad Uthman",
"url": "https://questionsmedicales.fr/author/Imad%20Uthman",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon."
}
},
{
"@type": "Person",
"name": "Katrien M J Devreese",
"url": "https://questionsmedicales.fr/author/Katrien%20M%20J%20Devreese",
"affiliation": {
"@type": "Organization",
"name": "Coagulation Laboratory, Ghent University Hospital, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium."
}
},
{
"@type": "Person",
"name": "Yu Zuo",
"url": "https://questionsmedicales.fr/author/Yu%20Zuo",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Antimicrobial photodynamic in vitro inactivation of Enterococcus spp. and Staphylococcus spp. strains using tetra-cationic platinum(II) porphyrins.",
"datePublished": "2023-03-30",
"url": "https://questionsmedicales.fr/article/37003596",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pdpdt.2023.103542"
}
},
{
"@type": "ScholarlyArticle",
"name": "Chinese expert consensus on the application of live combined Bifidobacterium, Lactobacillus, and Enterococcus powder/capsule in digestive system diseases (2021).",
"datePublished": "2023-04-29",
"url": "https://questionsmedicales.fr/article/37119032",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jgh.16195"
}
},
{
"@type": "ScholarlyArticle",
"name": "Colorimetric detection of viable antibiotic resistant Enterococcus mediated by cordless operation of reverse transcription loop-mediated isothermal amplification.",
"datePublished": "2022-08-08",
"url": "https://questionsmedicales.fr/article/35952900",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbiotec.2022.08.002"
}
},
{
"@type": "ScholarlyArticle",
"name": "The LiaFSR-LiaX System Mediates Resistance of Enterococcus faecium to Peptide Antibiotics and to Aureocin A53- and Enterocin L50-Like Bacteriocins.",
"datePublished": "2023-05-23",
"url": "https://questionsmedicales.fr/article/37219451",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/spectrum.00343-23"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of a novel family B DNA polymerase from Enterococcus phage IME199 and its overproduction in Escherichia coli BL21(DE3).",
"datePublished": "2023-10-21",
"url": "https://questionsmedicales.fr/article/37865739",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12934-023-02228-6"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies auto-immunes",
"item": "https://questionsmedicales.fr/mesh/D001327"
},
{
"@type": "ListItem",
"position": 4,
"name": "Syndrome des anticorps antiphospholipides",
"item": "https://questionsmedicales.fr/mesh/D016736"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome des anticorps antiphospholipides - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome des anticorps antiphospholipides",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome des anticorps antiphospholipides",
"description": "Comment diagnostique-t-on le syndrome des anticorps antiphospholipides ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels critères sont utilisés pour le diagnostic ?\nLe diagnostic nécessite-t-il des symptômes cliniques ?\nPeut-on avoir le syndrome sans symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Enterococcus&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome des anticorps antiphospholipides",
"description": "Quels sont les symptômes courants du syndrome ?\nLe syndrome peut-il causer des douleurs ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils d'une personne à l'autre ?\nLe syndrome affecte-t-il la grossesse ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Enterococcus&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome des anticorps antiphospholipides",
"description": "Comment prévenir les complications du syndrome ?\nY a-t-il des changements de mode de vie recommandés ?\nLes femmes enceintes doivent-elles être surveillées ?\nLes vaccinations sont-elles importantes ?\nLe stress a-t-il un impact sur le syndrome ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Enterococcus&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome des anticorps antiphospholipides",
"description": "Quels traitements sont disponibles pour le syndrome ?\nLes anticoagulants sont-ils efficaces ?\nLe traitement est-il à vie ?\nY a-t-il des effets secondaires aux traitements ?\nLes femmes enceintes peuvent-elles être traitées ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Enterococcus&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome des anticorps antiphospholipides",
"description": "Quelles sont les complications possibles du syndrome ?\nLe syndrome peut-il causer des problèmes cardiaques ?\nY a-t-il des risques pour la santé mentale ?\nLes complications sont-elles réversibles ?\nLe syndrome augmente-t-il le risque de cancer ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Enterococcus&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome des anticorps antiphospholipides",
"description": "Quels sont les facteurs de risque du syndrome ?\nLe sexe influence-t-il le risque ?\nLes antécédents de thromboses augmentent-ils le risque ?\nLes infections virales sont-elles un facteur de risque ?\nLe tabagisme influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Enterococcus&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on le syndrome des anticorps antiphospholipides ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins pour détecter les anticorps antiphospholipides."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le lupus anticoagulant, les anticorps anti-cardiolipine et anti-bêta-2-glycoprotéine I."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent des antécédents de thromboses et la présence d'anticorps spécifiques."
}
},
{
"@type": "Question",
"name": "Le diagnostic nécessite-t-il des symptômes cliniques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de thromboses ou de complications obstétricales sont souvent requis."
}
},
{
"@type": "Question",
"name": "Peut-on avoir le syndrome sans symptômes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent avoir des anticorps sans présenter de symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du syndrome ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des thromboses, des fausses couches et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il causer des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs peuvent survenir en raison de thromboses dans les vaisseaux sanguins."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme des maux de tête, des AVC ou des troubles cognitifs peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les individus."
}
},
{
"@type": "Question",
"name": "Le syndrome affecte-t-il la grossesse ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner des complications comme des fausses couches ou des prééclampsies."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications du syndrome ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut la prise régulière d'anticoagulants et le suivi médical."
}
},
{
"@type": "Question",
"name": "Y a-t-il des changements de mode de vie recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un poids santé, faire de l'exercice et éviter le tabac sont conseillés."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles être surveillées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance étroite est essentielle pour prévenir les complications obstétricales."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent aider à prévenir certaines infections qui aggravent le syndrome."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur le syndrome ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut exacerber les symptômes, donc des techniques de gestion du stress sont utiles."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le syndrome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des anticoagulants et des médicaments immunosuppresseurs."
}
},
{
"@type": "Question",
"name": "Les anticoagulants sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticoagulants réduisent le risque de thromboses chez les patients atteints."
}
},
{
"@type": "Question",
"name": "Le traitement est-il à vie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, mais de nombreux patients nécessitent un traitement à long terme."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticoagulants peuvent causer des saignements et d'autres effets indésirables."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes peuvent-elles être traitées ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anticoagulants comme l'héparine sont souvent utilisés pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du syndrome ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des thromboses veineuses profondes, des AVC et des fausses couches."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il causer des problèmes cardiaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut augmenter le risque de maladies cardiovasculaires et d'infarctus."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour la santé mentale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles anxieux et dépressifs peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent avoir des effets durables."
}
},
{
"@type": "Question",
"name": "Le syndrome augmente-t-il le risque de cancer ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien possible, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du syndrome ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des infections."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le syndrome est plus fréquent chez les femmes, surtout entre 20 et 40 ans."
}
},
{
"@type": "Question",
"name": "Les antécédents de thromboses augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents de thromboses augmente significativement le risque de syndrome."
}
},
{
"@type": "Question",
"name": "Les infections virales sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le VIH, peuvent augmenter le risque de développer le syndrome."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de thromboses et de complications."
}
}
]
}
]
}
This manuscript presents the first report on antimicrobial photo-inactivation in vitro using tetra-cationic porphyrins with peripheral platinum(II) bipyridyl complexes against Gram-positive bacteria. ...
Disturbance of gut microbiota is associated with pathological change in multiple diseases. Probiotics can improve symptoms and exert clinical effects via regulation of gastrointestinal microecological...
Following a literature search, evidence was graded and classified according to the grading of recommendations assessment, development, and evaluation (GRADE) system and consensus was secured from a pa...
An expert consensus has been formed, on the clinical application of live combined Bifidobacterium, Lactobacillus, and Enterococcus in various digestive system diseases, to provide reference for its cl...
Bifidobacterium triple viable powder/capsule may offer benefits, by regulating the balance of intestinal microecology. It can be used for the treatment and prevention of various digestive system disea...
In this study, we applied a tube-based reverse transcription loop-mediated isothermal amplification technique using preloaded amplification and detection reagents for simple screening of viable vancom...
Multidrug-resistant Enterococcus faecium strains are currently a leading cause of difficult-to-treat nosocomial infections. The emerging resistance of enterococci to last-resort antibiotics, such as d...
Identification and characterization of novel, faithful and processive DNA polymerases is a driving force in the development of DNA amplification methods. Purification of proteins from natural phages i...
We expressed the gene encoding Enterococcus faecium phage IME199 DNA polymerase (IME199 DNAP) in Escherichia coli BL21(DE3), and characterized protein function. IME199 DNAP has 3'-5' exonuclease activ...
A novel family B DNA polymerase was successfully overproduced in Escherichia coli BL21(DE3). Based on the characterized properties, IME199 DNAP is expected to be developed as a high-fidelity polymeras...
We studied the kinetics of growth of biofilms and plankton forms of Enterococcus spp. strains isolated in implant-associated infection of large joints. The capacity for biofilm formation by enterococc...
On-site hospital wastewater treatment system widely applying chlorination has been regarded as an important barrier to curb the dissemination of antibiotic resistance. Chlorination-residual viable and...
Different methods are used to determine the minimum inhibitory concentration (MIC) for daptomycin. The threshold is unknown for the free drug area under the concentration-time curve to MIC ratio (fAUC...
This is a retrospective cohort study. The inclusion criterion was VRE bacteremia treated with ≥ 8 mg/kg of daptomycin. As we aimed to compare different daptomycin MIC testing methods for predicting th...
A total of 393 patients were included; 215 survived and 178 died. In the multivariable logistic model for predicting mortality, the dichotomized fAUC/MICs for Etest and AST were 0.508 and 0.065 times ...
The dichotomized threshold for fAUC/MIC for BMD was the best predictor of mortality. An fAUC/MIC > 75.07 for BMD independently predicted better survival....
This study aimed to investigate the intestinal carrier status of Enterococcus spp. among children in a pediatric intensive care unit (PICU) and reveal the role of hospitalization in the alteration of ...
Two separate stool samples were collected from hospitalized patients in the pediatric intensive care unit at admission and discharge times. The culture was done, and Enterococcus species were tested f...
The results showed carriage of Enterococci at admission, discharge, and at both time points in 31%, 28.7%, and 40.1% of the cases, respectively. High frequencies of the fecal Enterococcus isolates wit...
The high rate of intestinal carriage of VR, HLGR-, and MDR-Enterococci at admission and during hospitalization in the PICU, and the impact of increased length of hospital stay on the fecal carriage of...
Nanotechnology presents an innovative strategy to combat the spread of antibiotic resistant bacteria and their resistance genes throughout different ecosystems. To address this challenge, nanoparticle...